mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.03 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.03 |
mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.03 |
mRNA |
regorafenib |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.03 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.03 |
mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.03 |
mRNA |
Obatoclax Mesylate |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.03 |
mRNA |
foretinib |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.04 |
mRNA |
SB-743921 |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.04 |
mRNA |
KPT185 |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.04 |